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Angiosome Important in Selecting Bypass Target Artery?’Dear Editor,
We would like to thank the authors of the letter for their perti-
nent comments on our manuscript. We fully agree that CLI treat-
ment cannot be accomplished by surgery alone and recognise the
importance of postoperative care, including wound management
and medication. In our manuscript, we emphasise that healing
ischaemic wounds is not easy, even after successful revasculariza-
tion, because of the impaired wound healing ability and impaired
immune system of compromised patients, such as those with dia-
betes or end-stage renal disease (ESRD).
As mentioned in the manuscript, we employ negative pressure
wound therapy (NPWT) for most deep wounds to facilitate granu-
lation formation. NPWT is one of greatest advances in the ﬁeld of
wound management and may contribute to shortened ulcer heal-
ing time.1 Conversely, hyperbaric oxygen therapy (HBO) is not
used routinely in our institution because of its inaccessibility.
Further randomised studies are required to evaluate whether
HBO has beneﬁts even in revascularised feet. To stimulate cell
growth and accomplish complete epithelialisation, a recombinant
ﬁbroblast growth factor (FGF) spray was applied to most of patient
wounds. Although, in this study, more than several months were
required to heal ischaemic ulcers in patients with ESRD despite
employing NPWT and the FGF spray, new bioengineered technolo-
gies for stimulating angiogenesis and new advancedwound healing
technologies are expected.2
Currently, there is no clear recommendation for postoperative
medication in CLI patients that is supported by strong evidence.
A portion of our patients (25%) experienced critically low graft
ﬂow as a result of poor run-off. To improve the microcirculation
and increase graft ﬂow, those patients underwent a prosta-
glandin E1 infusion through the vein graft. While all patients
were postoperatively administrated antiplatelet agents, cilosta-
zole was selected to 38% of patients to prevent progressive
vein graft intimal hyperplasia and life-threatening cardiovascular
events.
Further basic and clinical studies are required to examine post-
operative standard care and to improvewound healing and the QOL
of CLI patients.References
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doi:10.1016/j.ejvs.2012.04.003Antegradly Performed TEVARWe congratulate the authors for their work on the incidence of
stroke in thoracic endovascular aortic replacement (TEVAR) due to
arcus aorta aneursyms.1 We wonder if TEVAR,performed in 32
patients in whom zone 0 was intervened, was performed in the
same sitting with surgical intervention to ascending aorta. We
would like to know how TEVAR was performed if TEVAR was
carried out in the same session. That’s because if TEVAR is per-
formed in the same session as surgical procedure it can be done
antegradely from ascending aorta rather than the retrograde tech-
nique in which femoral artery is utilized. In this technique a 8-mm
graft is anastomosed to ascending aorta or the graft interposed to
ascending aorta. TEVAR is performed antegradely with this 8-mm
graft.2 Performing this procedure by antegrade route provides
such advantages as avoiding complications likely to develop in
the iliofemoral artery used as the site of access during the proce-
dure and ensuring sufﬁcient length in order for the endograft
deployment systems to reach the landing zones.2,3 Moreover, pres-
ence of shorter carrier systems in the antegrade approach will
cause delivery of less rotational power, thus providing maximum
precision in the placement of the graft. Another advantage is that
antegrade approach permits manual manipulations of the endog-
raft in order to ﬁt it to a desired position in the aortic arch, thanks
to the open sternum.2,3 Apart from that, there appears to be a risk of
entering the false lumen in the femoral or iliac arteries upon using
the retrograde route especially in dissection cases. Under the light
of this knowledge we feel that it is essential to keep in mind that
TEVAR can be antegradely done too, particularly in cases with
thoracic aorta aneursyms where sternum is opened.
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doi:10.1016/j.ejvs.2012.03.026Response to Commentary on ‘The Wonders of New Available
Post-analysis CT Software in the Hands of Vascular Surgeons’With regard to the commentary on the article “The Wonders
of New Available Post-analysis CT Software in the Hands of
Vascular Surgeons” there are a few things we would like to
highlight.
We agree with the authors that, before adopting post-
processing software in clinical practice, some training is needed
in order to prevent the misuse of such a delicate tool. We also agree
with them that it should be mandatory to report the likelihood of
a graft failure. We don’t agree with them when they criticize the
use of open source post-processing software, for the four reasons
we give below.
First of all, we need to point out that the post-processing soft-
ware has been used in order to further improve diagnosis, and
not as the main instrument for primary clinical use. The authorsDOI of original article: 10.1016/j.ejvs.2012.01.011.followed the golden standard in this case and on this basis sug-
gested how the diagnosis could be improved through further
investigation.
In the second place, as far as we know, there are no guidelines
about the use of post-processing software, therefore no legal issues
are at stake in this case, and neither are ethical ones. Not only has
no harm been done to the patient, but, more importantly, no harm
could have been done.
Thirdly, there is growing literature in this ﬁeld1 about the great
effectiveness of open source software as compared to the approved
versions. Open source software is updated at a rate that exceeds by
far that of software updates in the industry, which makes it a better
and more reliable tool than the approved types.
Last but not least, it is the duty of the public service to adopt
a resource with the best cost-effectiveness ratio. In this case the
choice of software that is both open source and free of charge
and that could guarantee the same, if not better, level of reliability
than its approved and expensive version has been a responsible
one, and should not be subject to criticism.Reference
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doi:10.1016/j.ejvs.2012.04.023Reply to Letter Regarding the Comments on ‘The Wonders of
New Available Post-analysis CT Software in the Hands of
Vascular Surgeons’We feel obliged to reply to the letter regarding our previous
comments on the use of open-source software for image post-
processing, and explain our point of view some more. As we
previously emphasized, post-processing software is very
useful and can enhance insight in a patient’s anatomy before
and after endovascular aneurysm repair. In fact, detailed anal-
ysis using such technology may provide additional or alterna-
tive diagnoses and improve patient care. Naturally, a free
software tool that can provide this added value is a great
asset.DOI of original article: 10.1016/j.ejvs.2012.04.023.
